Page last updated: 2024-12-07
testosterone isobutyrate
Cross-References
ID Source | ID |
PubMed CID | 92149 |
SCHEMBL ID | 1318762 |
MeSH ID | M0091680 |
Synonyms (21)
Synonym |
testosterone isobutyrate |
testosterone 2-methylpropanoate |
testosterone 17-isobutyrate |
[(8r,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 2-methylpropanoate |
1169-49-9 |
SCHEMBL1318762 |
einecs 214-622-7 |
unii-h0knq242j5 |
h0knq242j5 , |
AKOS015902333 |
17.beta.-(isobutyroxy)androst-4-en-3-one |
testosterone 2-methylpropionate |
isobutyric acid, ester with testosterone |
testosterone isobutyrate [who-dd] |
3-oxoandrost-4-en-17.beta.-yl isobutyrat |
(17.beta.)-17-(2-methyl-1-oxopropoxy)androst-4-en-3-one |
testosterone propionate impurity b [ep impurity] |
DTXSID70151573 |
3-oxoandrost-4-en-17beta-yl 2-methyl-propanoate (testosterone isobutyrate) |
Q27279416 |
testosteroneisobutyrate |
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 7 (77.78) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |